Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/19/15 → 3/19/18 |
Funding
- Therapeutics, Inc. (Prot #X052171)
- XOMA (US) LLC (Prot #X052171)
Prot #X052171: A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients with Pyoderma Gangrenosum
- Laumann, Anne E (PD/PI)
Project: Research project